Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: The University of California-San Francisco experience

Cancer

Volumn 113, Issue 3, 2008, Pages 497-507

  Huang, Kim ^a   Xia, Ping ^a   Chuang, Cynthia ^a   Weinberg, Vivian ^a   Glastonbury, Christine M ^b   Eisele, David W ^b   Lee, Nancy Y ^a   Yom, Sue S ^a   Phillips, Theodore L ^a   Quivey, Jeanne M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemotherapy; Cisplatin; Head and neck cancer; Intensity modulated radiotherapy; Locally advanced; Oropharyngeal carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; FLUORODEOXYGLUCOSE F 18; PACLITAXEL; PLATINUM;

ADULT; AGED; ARTICLE; BONE NECROSIS; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DERMATITIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GASTROSTOMY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MANDIBLE; MUCOSA INFLAMMATION; NECK DISSECTION; NEPHROTOXICITY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CARCINOMA; OTOTOXICITY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TONSIL CARCINOMA; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT; XEROSTOMIA;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CALIFORNIA; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SAN FRANCISCO; TREATMENT OUTCOME;

EID: 49049093209     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23578     Document Type: Article

References (41)

1. Blumberg AL, Fu KK, Phillips TL. Results of treatment of carcinoma of the base of the tongue, the UCSF experience, 1957-1976. Int J Radiat Oncol Biol Phys. 1979;5:1971-1976.
2. Mizono GS, Diaz RF, Fu KK, et al. Carcinoma of the tonsillar region. Laryngoscope. 1986;96:240-244.
3. Fein DA, Lee WR, Amos WR, et al. Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience. Int J Radiat Oncol Biol Phys. 1996;34:289-296.
4. Foote RL, Olsen KD, Davis DL, et al. Base of tongue carcinoma: patterns of failure and predictors of recurrence after surgery alone. Head Neck. 1993;15:300-307.
5. Sardi A, Walters PJ. Modified mandibular swing procedure for resection of carcinoma of the oropharynx. Head Neck. 1991;13:394-397.
6. Foote RL, Schild SE, Thompson WM, et al. Tonsil cancer. Patterns of failure after surgery alone and surgery combined with postoperative radiation therapy. Cancer. 1994;73:2638-2647.
7. Kraus DH, Vastola AP, Huvos AG, et al. Surgical management of squamous cell carcinoma of the base of the tongue. Am J Surg. 1993;166:384-388.
8. Perez CA, Carmichael T, Devineni VR, et al. Carcinoma of the tonsillar fossa: a nonrandomized comparison of irradiation alone or combined with surgery: long-term results. Head Neck. 1991;13:282-290.
9. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91:2081-2086.
10. Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer. 2002;94:2967-2980.
11. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92-98.
12. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798-1804.
13. Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004;22:69-76.
14. Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol. 2000;18:1458-1464.
15. Staar S, Rudat V, Stuetzer H, et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy: results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:1161-1171.
16. Wendt TG, Grabenbauer GG, Rodel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol. 1998;16:1318-1324.
17. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000;355:949-955.
18. Verhey LJ. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems. Semin Radiat Oncol. 1999;9:78-98.
19. Hong TS, Tome WA, Chappell RJ, et al. Variations in target delineation for head and neck IMRT: an international multi-institutional study. Int J Radiat Oncol Biol Phys 2004;60(suppl 1):S157-S158.
20. Sultanem K, Shu HK, Xia P, et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2000;48:711-722.
21. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12-22.
22. Lee N, Xia P, Fischbein NJ, et al. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys. 2003;57:49-60.
23. Green FL, Page DL, Fleming ID, et al. AJCC manual for staging of cancer. 6th ed. Philadelphia: Lippincott; 2002.
24. Xia P, Fu KK, Wong GW, et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:329-337.
25. Hansen EK, Bucci MK, Quivey JM, et al. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;64:355-362.
26. Rembert JL, Xia P, Bucci MK, et al. Dosimetric uncertainties in matched IMRT and conventional fields for head and neck cancer radiotherapy. Int J Radiat Oncol Biol Phys 2004;60(suppl 1):516-517.
27. Lee N, Akazawa C, Akazawa P, et al. A forward-planned treatment technique using multisegments in the treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;59:584-594.
28. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) [editorial]. Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
29. Garden AS, Morrison WH, Wong PF, et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007;67:438-444.
30. de Arruda FF, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys. 2006;64:363-373.
31. Chao KS, Ozyigit G, Blanco AI, et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys. 2004;59:43-50.
32. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys. 2004;59:28-42.
33. Sanguineti G, Culp LR, Endres EJ, et al. Are neck nodal volumes drawn on CT slices covered by standard 3-field technique? Int J Radiat Oncol Biol Phys. 2004;59:725-742.
34. Chao KS, Ozyigit G, Tran BN, et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003;55:312-321.
35. Amosson CM, Teh BS, Garg AK, et al. Accelerated fractionation for head and neck cancer using the SMART (Simultaneous Modulated Accelerated Radiation Therapy) boost technique. Int J Radiat Oncol Biol Phys. 2003;57(2 suppl):S306-S307.
36. Lauve A, Morris M, Schmidt-Ullrich R, et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas, II: clinical results. Int J Radiat Oncol Biol Phys. 2004;60:374-387.
37. Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume, and function relationships in parotid salivary glands following conformai and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577-587.
38. Bucci MK, Cabrera AR, Hansen EK, et al. Importance of Accurate Delineation of Parotid Glands in Intensity Modulated Radiotherapy. Presented at the 4th S. Takahashi Memorial Internationl Workshop on 3-Dimensional Conformal Radiothrapy. Dec 2004, Nagoya, Japan.
39. Pletcher SD, Kaplan MJ, Eisele DW, et al. Management of cervical metastases in advanced squamous cell carcinoma of the base of tongue. Arch Otolaryngol Head Neck Surg. 2003;129:983-986.
40. Mau T, Oh Y, Bucci MK, et al. Management of cervical metastases in advanced squamous cell carcinoma of the tonsillar fossa following radiotherapy. Arch Otolaryngol Head Neck Surg. 2005;131:600-604.
41. Yao M, Graham MM, Smith RB, et al. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report. Int J Radiat Oncol Biol Phys. 2004;60:1410-1418.